BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26381553)

  • 21. Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.
    Rimelen V; Ahle G; Pencreach E; Zinniger N; Debliquis A; Zalmaï L; Harzallah I; Hurstel R; Alamome I; Lamy F; Voirin J; Drénou B
    Acta Neuropathol Commun; 2019 Mar; 7(1):43. PubMed ID: 30885253
    [No Abstract]   [Full Text] [Related]  

  • 22. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.
    Kang Y; Choi SH; Kim YJ; Kim KG; Sohn CH; Kim JH; Yun TJ; Chang KH
    Radiology; 2011 Dec; 261(3):882-90. PubMed ID: 21969667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma.
    Galicia N; Dégano R; Díez P; González-González M; Góngora R; Ibarrola N; Fuentes M
    Expert Rev Proteomics; 2017 Apr; 14(4):363-372. PubMed ID: 28293970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokine CXC Ligand 13 in Cerebrospinal Fluid Can Be Used as an Early Diagnostic Biomarker for Lyme Neuroborreliosis: A Meta-Analysis.
    Yang J; Han X; Liu A; Bao F; Peng Y; Tao L; Ma M; Bai R; Dai X
    J Interferon Cytokine Res; 2017 Oct; 37(10):433-439. PubMed ID: 28972436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
    Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
    Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
    Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
    Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of Enhancing Glioma and Primary Central Nervous System Lymphoma by Texture-Based Machine Learning.
    Alcaide-Leon P; Dufort P; Geraldo AF; Alshafai L; Maralani PJ; Spears J; Bharatha A
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1145-1150. PubMed ID: 28450433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orbital Indeterminate Lesions in Adults: Combined Magnetic Resonance Morphometry and Histogram Analysis of Apparent Diffusion Coefficient Maps for Predicting Malignancy.
    Xu XQ; Hu H; Su GY; Zhang L; Liu H; Hong XN; Shi HB; Wu FY
    Acad Radiol; 2016 Feb; 23(2):200-8. PubMed ID: 26625705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers.
    Liba Z; Nohejlova H; Capek V; Krsek P; Sediva A; Kayserova J
    PLoS One; 2019; 14(7):e0219987. PubMed ID: 31356620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.
    Baraniskin A; Kuhnhenn J; Schlegel U; Chan A; Deckert M; Gold R; Maghnouj A; Zöllner H; Reinacher-Schick A; Schmiegel W; Hahn SA; Schroers R
    Blood; 2011 Mar; 117(11):3140-6. PubMed ID: 21200023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
    Ko CC; Tai MH; Li CF; Chen TY; Chen JH; Shu G; Kuo YT; Lee YC
    PLoS One; 2016; 11(9):e0162565. PubMed ID: 27631626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic approach to the diagnosis of suspected central nervous system lymphoma.
    Scott BJ; Douglas VC; Tihan T; Rubenstein JL; Josephson SA
    JAMA Neurol; 2013 Mar; 70(3):311-9. PubMed ID: 23319132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.
    van Westrhenen A; Smidt LCA; Seute T; Nierkens S; Stork ACJ; Minnema MC; Snijders TJ
    Br J Haematol; 2018 Aug; 182(3):384-403. PubMed ID: 29808930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation.
    Kang D; Park JE; Kim YH; Kim JH; Oh JY; Kim J; Kim Y; Kim ST; Kim HS
    Neuro Oncol; 2018 Aug; 20(9):1251-1261. PubMed ID: 29438500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases.
    Caravan I; Ciortea CA; Contis A; Lebovici A
    Acta Radiol; 2018 May; 59(5):599-605. PubMed ID: 28835111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.
    Mikecin L; Krizmaric M; Stepan Giljevic J; Gjurasin M; Kern J; Lenicek Krleza J; Popovic L
    Croat Med J; 2013 Oct; 54(5):429-35. PubMed ID: 24170721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma.
    Schob S; Meyer J; Gawlitza M; Frydrychowicz C; Müller W; Preuss M; Bure L; Quäschling U; Hoffmann KT; Surov A
    PLoS One; 2016; 11(8):e0161386. PubMed ID: 27571268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
    Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
    AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grading of Gliomas by Using Monoexponential, Biexponential, and Stretched Exponential Diffusion-weighted MR Imaging and Diffusion Kurtosis MR Imaging.
    Bai Y; Lin Y; Tian J; Shi D; Cheng J; Haacke EM; Hong X; Ma B; Zhou J; Wang M
    Radiology; 2016 Feb; 278(2):496-504. PubMed ID: 26230975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
    Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z
    Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.